SCHEMBL8059650

SCHEMBL8059650

O=C(C=Cc1ccc(C(F)(F)F)cc1)Nc1ccc(Cl)cc1C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.70
TRPM8 Q7Z2W7 1/20 0.70
TRPM2 O94759 2/20 0.57
MAOB P27338 3/20 0.56
EGFR P00533 1/20 0.55
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C19 P33261 1/20 0.54
HDAC3 O15379 1/20 0.53
ADAM17 P78536 1/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC2 Q92769 1/20 0.53
HDAC10 Q969S8 1/20 0.53
HDAC11 Q96DB2 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
HDAC5 Q9UQL6 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8059645 1.00 TRPA1 (0.70) TRPA1TRPM8TRPM2MAOBEGFR
SCHEMBL8061782 0.91 TRPA1 (0.70) TRPA1TRPM8TRPM2MAOBEGFR
SCHEMBL8061780 0.91 TRPA1 (0.70) TRPA1TRPM8TRPM2MAOBEGFR
SCHEMBL8065883 0.89 TRPA1 (0.75) TRPA1TRPM8TRPM2EGFRMEN1
SCHEMBL8065880 0.89 TRPA1 (0.75) TRPA1TRPM8TRPM2EGFRMEN1
SCHEMBL8065358 0.87 KDM4E (0.60) TRPA1TRPM8TRPM2MAOBEGFR
SCHEMBL8065360 0.87 KDM4E (0.60) TRPA1TRPM8TRPM2MAOBEGFR
SCHEMBL8065971 0.86 TRPA1 (0.68) TRPA1TRPM8TRPM2EGFRMEN1
SCHEMBL8065974 0.86 TRPA1 (0.68) TRPA1TRPM8TRPM2EGFRMEN1
SCHEMBL8060457 0.85 EGFR (0.75) TRPA1TRPM8TRPM2MAOBEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US disclosed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US disclosed